$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Hedge Funds Are Betting On Castle Biosciences, Inc. (CSTL)
02:38pm, Friday, 26'th Jun 2020
In this article we will check out the progression of hedge fund sentiment towards Castle Biosciences, Inc. (NASDAQ:CSTL) and determine whether it is a good investment right now. We at Insider Monkey l
Castle Biosciences Announces Pricing of $74.0 Million Public Offering of Common Stock
01:33am, Thursday, 25'th Jun 2020
Castle Biosciences announced today the pricing of its underwritten public offering.
Castle Biosciences Announces Pricing of $74.0 Million Public Offering of Common Stock
12:00am, Thursday, 25'th Jun 2020
Castle Biosciences announced today the pricing of its underwritten public offering.
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock
08:34pm, Monday, 22'nd Jun 2020Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock
08:33pm, Monday, 22'nd Jun 2020
Castle Biosciences has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC).
Castle Biosciences Announces Proposed Underwritten Public Offering of Common Stock
12:00am, Monday, 22'nd Jun 2020
Castle Biosciences has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC).
The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs
12:00am, Friday, 19'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 18)
ADC Therapeutics SA (NYSE:...
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO
12:00am, Tuesday, 16'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 16)
Applied Molecular Transport...
Joseph C. Cook III Sells 2,108 Shares of Castle Biosciences (NASDAQ:CSTL) Stock
06:56am, Sunday, 14'th Jun 2020
Castle Biosciences (NASDAQ:CSTL) Director Joseph C. Cook III sold 2,108 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $39.00
Castle Biosciences (NASDAQ:CSTL) and Anpac Bio-Medical Science (NASDAQ:ANPC) Head-To-Head Survey
03:10am, Sunday, 14'th Jun 2020
Castle Biosciences (NASDAQ:CSTL) and Anpac Bio-Medical Science (NASDAQ:ANPC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the st
GenMark (GNMK) Receives a Buy from Canaccord Genuity - Markets
03:22am, Thursday, 11'th Jun 2020
Canaccord Genuity analyst Max Masucci maintained a Buy rating on GenMark (GNMK – Research Report) yesterday and set a price
Skin cancer symptoms: The sign in your feet that could signal the deadly disease
10:00am, Monday, 01'st Jun 2020
SKIN cancer symptoms most often develop on areas of the skin that have been exposed to the sun, but it can also develop on less obvious areas such as the feet. One sign of melanoma skin cancer - one o
Castle Biosciences Announces Change of Location of Annual Meeting of Stockholders to Be Held June 4, 2020
11:00am, Friday, 22'nd May 2020
Castle announced a change of location of its 2020 Annual Meeting of Stockholders to The San Luis Hotel, 5222 Seawall Blvd., Galveston, TX, 77550.
Castle Bisociences Grows Despite Covid19 Damping (NASDAQ:CSTL)
05:32pm, Thursday, 21'st May 2020
Castle Biosciences went public in July 2019 at $16.00 per share. The firm provides a variety of diagnostic and predictive testing for skin cancers. CSTL has imp
Sign In
Buy CSTL